STOMP during COVID-19: use of psychotropic medication in intellectual disabilities community services – pilot QI project

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1COVID-19 and people with intellectual disability: impacts of a pandemic2020 · 427 citations
2. 2Priority concerns for people with intellectual and developmental disabilities during the COVID-19 pandemic2020 · 63 citations
3. 3The improved Clinical Global Impression Scale (iCGI): development and validation in depression2007 · 208 citations
4. 4Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients’ primary care records in situ using OpenSAFELY2023 · 15 citations
5. 5COVID-19-related prescribing challenge in intellectual disability2021 · 36 citations